Related Experiment Videos
The use of technetium-99m sestamibi to indicate breast cancer invasiveness
European Journal of Nuclear Medicine
|June 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Validation, implementation and quality control of a Torque Teno Virus qPCR in a multinational clinical trial.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2024
[Case report of a cystic lung disease: From a rarity to the discovery of an unknown genetic variant].
Revue des maladies respiratoires·2024
(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
European journal of nuclear medicine·2014
The clinical value of (18)F-FDG detection with a dual-head coincidence camera: a review.
European journal of nuclear medicine·2014
In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection.
European journal of nuclear medicine·2014
The value of oblique pinhole images in pre-operative localisation with (99m)Tc-MIBI for primary hyperparathyroidism.
European journal of nuclear medicine·2014
Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods.
European journal of nuclear medicine·2014
Monitoring the chemotherapeutic response in primary lung cancer using (99m)Tc-MIBI SPET.
European journal of nuclear medicine·2014
Computed tomographic Characteristics of Presumed Normal Canine Iliosacral Lymph Nodes.
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2026
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.
Molecular therapy. Nucleic acids·2026
Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review.
Frontiers in immunology·2026
Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma.
Journal of translational medicine·2026